Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

Journal of Thoracic Oncology

Saved in:

Bibliographic Details
Main Authors:	Lim, E.H., Zhang, S.-L., Li, J.-L., Yap, W.-S., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M., Chang, A., Ng, A., Tan, P.
Other Authors:	STATISTICS & APPLIED PROBABILITY
Format:	Article
Published:	2014
Subjects:	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/105456
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-105456
record_format	dspace
spelling	sg-nus-scholar.10635-1054562024-11-08T20:03:59Z Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC) Lim, E.H. Zhang, S.-L. Li, J.-L. Yap, W.-S. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. Chang, A. Ng, A. Tan, P. STATISTICS & APPLIED PROBABILITY Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification Journal of Thoracic Oncology 4 1 12-21 2014-10-28T05:16:27Z 2014-10-28T05:16:27Z 2009-01 Article Lim, E.H., Zhang, S.-L., Li, J.-L., Yap, W.-S., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M., Chang, A., Ng, A., Tan, P. (2009-01). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 4 (1) : 12-21. ScholarBank@NUS Repository. 15560864 http://scholarbank.nus.edu.sg/handle/10635/105456 000262196500003 Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
spellingShingle	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification Lim, E.H. Zhang, S.-L. Li, J.-L. Yap, W.-S. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. Chang, A. Ng, A. Tan, P. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
description	Journal of Thoracic Oncology
author2	STATISTICS & APPLIED PROBABILITY
author_facet	STATISTICS & APPLIED PROBABILITY Lim, E.H. Zhang, S.-L. Li, J.-L. Yap, W.-S. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. Chang, A. Ng, A. Tan, P.
format	Article
author	Lim, E.H. Zhang, S.-L. Li, J.-L. Yap, W.-S. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M. Chang, A. Ng, A. Tan, P.
author_sort	Lim, E.H.
title	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_short	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_full	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_fullStr	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_full_unstemmed	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
title_sort	using whole genome amplification (wga) of low-volume biopsies to assess the prognostic role of egfr, kras, p53, and cmet mutations in advanced-stage non-small cell lung cancer (nsclc)
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/105456
_version_	1821221172917829632

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

Similar Items